BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30324868)

  • 1. Insurance Status and Survival of Patients with Salivary Gland Cancer.
    Saraswathula A; Megwalu UC
    Otolaryngol Head Neck Surg; 2018 Dec; 159(6):998-1005. PubMed ID: 30324868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
    Smartt AA; Jang ES; Tyler WK
    Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study.
    Rong X; Yang W; Garzon-Muvdi T; Caplan JM; Hui X; Lim M; Huang J
    Cancer; 2016 Oct; 122(20):3157-3165. PubMed ID: 27500668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance Status Effect on Laryngeal Cancer Survival: A Population Based Study.
    Abt NB; Miller LE; Parikh A; Bhattacharyya N
    Ann Otol Rhinol Laryngol; 2022 Jul; 131(7):775-781. PubMed ID: 34486418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
    Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
    Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of payer status on survival in parotid malignancy.
    Stubbs VC; Rajasekaran K; Chen J; Cannady SB; Brant JA; Newman JG
    Am J Otolaryngol; 2019; 40(4):555-559. PubMed ID: 31097206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
    Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
    Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.
    Churilla T; Egleston B; Dong Y; Shaikh T; Murphy C; Mantia-Smaldone G; Chu C; Rubin S; Anderson P
    Gynecol Oncol; 2016 Jun; 141(3):516-523. PubMed ID: 27012428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study.
    Perry AM; Brunner AM; Zou T; McGregor KL; Amrein PC; Hobbs GS; Ballen KK; Neuberg DS; Fathi AT
    Cancer; 2017 Jul; 123(13):2561-2569. PubMed ID: 28464280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insurance status, stage of presentation, and survival among female patients with head and neck cancer.
    Panth N; Simpson MC; Sethi RKV; Varvares MA; Osazuwa-Peters N
    Laryngoscope; 2020 Feb; 130(2):385-391. PubMed ID: 30900256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Insurance Affects Head and Neck Cancer Treatment Patterns and Outcomes.
    Inverso G; Mahal BA; Aizer AA; Donoff RB; Chuang SK
    J Oral Maxillofac Surg; 2016 Jun; 74(6):1241-7. PubMed ID: 26851312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of health insurance status on the survival of patients with head and neck cancer.
    Kwok J; Langevin SM; Argiris A; Grandis JR; Gooding WE; Taioli E
    Cancer; 2010 Jan; 116(2):476-85. PubMed ID: 19937673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insurance status is related to diffuse large B-cell lymphoma survival.
    Han X; Jemal A; Flowers CR; Sineshaw H; Nastoupil LJ; Ward E
    Cancer; 2014 Apr; 120(8):1220-7. PubMed ID: 24474436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insurance status as a predictor of mortality in patients undergoing head and neck cancer surgery.
    Rohlfing ML; Mays AC; Isom S; Waltonen JD
    Laryngoscope; 2017 Dec; 127(12):2784-2789. PubMed ID: 28639701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Insurance Status on Stage, Treatment, and Survival in Patients with Colorectal Cancer: A Population-Based Analysis.
    Sun W; Cheng M; Zhuang S; Qiu Z
    Med Sci Monit; 2019 Apr; 25():2397-2418. PubMed ID: 30939127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
    Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
    Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insurance status is related to overall survival in patients with small intestine adenocarcinoma: A population-based study.
    Wang N; Bu Q; Yang J; Liu Q; He H; Liu J; Ren X; Lyu J
    Curr Probl Cancer; 2020 Feb; 44(1):100505. PubMed ID: 31548047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer.
    Fossati N; Nguyen DP; Trinh QD; Sammon J; Sood A; Larcher A; Guazzoni G; Montorsi F; Briganti A; Menon M; Abdollah F
    J Natl Compr Canc Netw; 2015 Nov; 13(11):1351-8. PubMed ID: 26553765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status.
    Amini A; Yeh N; Jones BL; Bedrick E; Vinogradskiy Y; Rusthoven CG; Amini A; Purcell WT; Karam SD; Kavanagh BD; Guntupalli SR; Fisher CM
    Am J Clin Oncol; 2018 May; 41(5):476-484. PubMed ID: 27281264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival disparities by insurance type for patients aged 15-64 years with non-Hodgkin lymphoma.
    Pulte D; Jansen L; Brenner H
    Oncologist; 2015 May; 20(5):554-61. PubMed ID: 25876991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.